Public EUDAMED Search

EUDAMED Device Search

A readable public search layer for EUDAMED device, manufacturer, UDI, EMDN and risk class data.

Last updated

01.08.2026 09:11

Sync status

Successful

Device

2989308

Actor

47520

Certificate

3174

Active filter:Manufacturer SRN:FR-MF-000027377

7 device results listed.

Page 1 / 1

mAbXmise IADA1

mAbXmise – Anti-drug antibodies quantification Kit multiplex ANTI-Infliximab & ANTI-Adalimumab

IVD Class BIVDR 2017/746On the marketAnimal tissuesDirect markingHuman tissuesKitProfessional testingReagent
Manufacturer
Promise proteomics
Manufacturer SRN
FR-MF-000027377
UDI-DI
03770024131079
Basic UDI-DI
3770024131INF-ADAX3
Reference
IADA1
EMDN
W01020899
EMDN description
THERAPEUTIC DRUG MONITORING - OTHER
First on market country
France
Authorised representative
-
Last updated
30.07.2026 21:57
mAbXmise PNHTDM

mAbXmise – Monoclonal antibodies quantification Kit Eculizumab or Ravulizumab

IVD Class BIVDR 2017/746On the marketAnimal tissuesDirect markingHuman tissuesKitProfessional testingReagent
Manufacturer
Promise proteomics
Manufacturer SRN
FR-MF-000027377
UDI-DI
03770024131055
Basic UDI-DI
3770024131PNH-TDM7A
Reference
PNHTDM
EMDN
W01020899
EMDN description
THERAPEUTIC DRUG MONITORING - OTHER
First on market country
France
Authorised representative
-
Last updated
30.07.2026 21:57
mAbXmise HTDM

mAbXmise – Monoclonal antibody quantification Kit Emicizumab

IVD Class BIVDR 2017/746On the marketAnimal tissuesDirect markingHuman tissuesKitProfessional testingReagent
Manufacturer
Promise proteomics
Manufacturer SRN
FR-MF-000027377
UDI-DI
03770024131048
Basic UDI-DI
3770024131HEM-TDMYZ
Reference
HTDM
EMDN
W01020899
EMDN description
THERAPEUTIC DRUG MONITORING - OTHER
First on market country
France
Authorised representative
-
Last updated
30.07.2026 21:57
mAbXmise ITDM2

mAbXmise – Monoclonal antibodies quantification Kit Multiplex Infliximab, Adalimumab, Obinutuzumab, Secukinumab, Tocilizumab, Ustekinumab, Vedolizumab

IVD Class BIVDR 2017/746On the marketAnimal tissuesDirect markingHuman tissuesKitProfessional testingReagent
Manufacturer
Promise proteomics
Manufacturer SRN
FR-MF-000027377
UDI-DI
03770024131000
Basic UDI-DI
3770024131INF-TDM2V
Reference
ITDM2
EMDN
W0102080701
EMDN description
INFLIXIMAB
First on market country
France
Authorised representative
-
Last updated
30.07.2026 21:57
mAbXmise GTDM

mAbXmise – Quantification kit Belatacept or Abatacept

IVD generalIVDDOn the marketAnimal tissuesHuman tissuesKitProfessional testingReagent
Manufacturer
Promise proteomics
Manufacturer SRN
FR-MF-000027377
UDI-DI
03770024131031
Basic UDI-DI
B-03770024131031
Reference
GTDM
EMDN
W01020899
EMDN description
THERAPEUTIC DRUG MONITORING - OTHER
First on market country
France
Authorised representative
-
Last updated
19.07.2026 20:47
mAbXmise OTDM1

mAbXmise – Monoclonal antibodies quantification Kit Multiplex Nivolumab, Pembrolizumab, Trastuzumab, Cetuximab, Bevacizumab, Ipilimumab, Rituximab

IVD generalIVDDOn the marketAnimal tissuesHuman tissuesKitProfessional testingReagent
Manufacturer
Promise proteomics
Manufacturer SRN
FR-MF-000027377
UDI-DI
03770024131024
Basic UDI-DI
B-03770024131024
Reference
OTDM1
EMDN
W0102080704
EMDN description
RITUXIMAB
First on market country
France
Authorised representative
-
Last updated
19.07.2026 20:47
mAbXmise ITDM1

mAbXmise – Monoclonal antibodies quantification Kit Multiplex Infliximab & Adalimumab

IVD generalIVDDOn the marketAnimal tissuesHuman tissuesKitProfessional testingReagent
Manufacturer
Promise proteomics
Manufacturer SRN
FR-MF-000027377
UDI-DI
03770024131017
Basic UDI-DI
B-03770024131017
Reference
ITDM1
EMDN
W0102080701
EMDN description
INFLIXIMAB
First on market country
France
Authorised representative
-
Last updated
19.07.2026 20:47